
Bong-sook Baek
Examiner (ID: 12986, Phone: (571)270-5863 , Office: P/1621 )
| Most Active Art Unit | 1611 |
| Art Unit(s) | 4161, 1621, 1629, 1611, 1614 |
| Total Applications | 1176 |
| Issued Applications | 496 |
| Pending Applications | 83 |
| Abandoned Applications | 613 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 8555285
[patent_doc_number] => 08329757
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-12-11
[patent_title] => 'Curcumin analog compositions and related methods'
[patent_app_type] => utility
[patent_app_number] => 12/579361
[patent_app_country] => US
[patent_app_date] => 2009-10-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 6244
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 9
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12579361
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/579361 | Curcumin analog compositions and related methods | Oct 13, 2009 | Issued |
Array
(
[id] => 6616077
[patent_doc_number] => 20100099696
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-04-22
[patent_title] => 'Tamper resistant oral dosage forms containing an embolizing agent'
[patent_app_type] => utility
[patent_app_number] => 12/587771
[patent_app_country] => US
[patent_app_date] => 2009-10-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 23
[patent_figures_cnt] => 23
[patent_no_of_words] => 23348
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0099/20100099696.pdf
[firstpage_image] =>[orig_patent_app_number] => 12587771
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/587771 | Tamper resistant oral dosage forms containing an embolizing agent | Oct 12, 2009 | Abandoned |
Array
(
[id] => 6257793
[patent_doc_number] => 20100029717
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-02-04
[patent_title] => 'Alkylsulphonamide Quinolines'
[patent_app_type] => utility
[patent_app_number] => 12/576319
[patent_app_country] => US
[patent_app_date] => 2009-10-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8942
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0029/20100029717.pdf
[firstpage_image] =>[orig_patent_app_number] => 12576319
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/576319 | Alkylsulphonamide quinolines | Oct 8, 2009 | Issued |
Array
(
[id] => 11766873
[patent_doc_number] => 09375387
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-06-28
[patent_title] => 'Ready-to-use, stable emulsion'
[patent_app_type] => utility
[patent_app_number] => 13/121962
[patent_app_country] => US
[patent_app_date] => 2009-10-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2318
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 107
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13121962
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/121962 | Ready-to-use, stable emulsion | Sep 30, 2009 | Issued |
Array
(
[id] => 6223453
[patent_doc_number] => 20100056637
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-03-04
[patent_title] => 'TREATMENT METHODS USING TRIARYL METHANE COMPOUNDS'
[patent_app_type] => utility
[patent_app_number] => 12/563097
[patent_app_country] => US
[patent_app_date] => 2009-09-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 15943
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0056/20100056637.pdf
[firstpage_image] =>[orig_patent_app_number] => 12563097
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/563097 | TREATMENT METHODS USING TRIARYL METHANE COMPOUNDS | Sep 17, 2009 | Abandoned |
Array
(
[id] => 6494330
[patent_doc_number] => 20100009939
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-01-14
[patent_title] => 'CONCURRENT DRUGS'
[patent_app_type] => utility
[patent_app_number] => 12/560733
[patent_app_country] => US
[patent_app_date] => 2009-09-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4519
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0009/20100009939.pdf
[firstpage_image] =>[orig_patent_app_number] => 12560733
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/560733 | CONCURRENT DRUGS | Sep 15, 2009 | Abandoned |
Array
(
[id] => 6615642
[patent_doc_number] => 20100003208
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-01-07
[patent_title] => 'Skin Care Products, As Well As Foods and Beverages Containing 6-O-PUFA Ascorbic Esters'
[patent_app_type] => utility
[patent_app_number] => 12/558986
[patent_app_country] => US
[patent_app_date] => 2009-09-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 4539
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0003/20100003208.pdf
[firstpage_image] =>[orig_patent_app_number] => 12558986
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/558986 | Skin Care Products, As Well As Foods and Beverages Containing 6-O-PUFA Ascorbic Esters | Sep 13, 2009 | Abandoned |
Array
(
[id] => 9469064
[patent_doc_number] => 08722696
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-05-13
[patent_title] => 'Process for preparing particles containing an antiviral'
[patent_app_type] => utility
[patent_app_number] => 12/553545
[patent_app_country] => US
[patent_app_date] => 2009-09-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11227
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 222
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12553545
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/553545 | Process for preparing particles containing an antiviral | Sep 2, 2009 | Issued |
Array
(
[id] => 5374848
[patent_doc_number] => 20090312409
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-12-17
[patent_title] => 'LIPOPEXIA INHIBITOR AND FOOD OR BEVERAGE'
[patent_app_type] => utility
[patent_app_number] => 12/549102
[patent_app_country] => US
[patent_app_date] => 2009-08-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4080
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0312/20090312409.pdf
[firstpage_image] =>[orig_patent_app_number] => 12549102
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/549102 | LIPOPEXIA INHIBITOR AND FOOD OR BEVERAGE | Aug 26, 2009 | Abandoned |
Array
(
[id] => 5374858
[patent_doc_number] => 20090312419
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-12-17
[patent_title] => 'CREATINE -ßALANINATE: A NOVEL SALT FOR INCREASING ATHLETIC PERFORMANCE'
[patent_app_type] => utility
[patent_app_number] => 12/545727
[patent_app_country] => US
[patent_app_date] => 2009-08-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 6104
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0312/20090312419.pdf
[firstpage_image] =>[orig_patent_app_number] => 12545727
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/545727 | CREATINE -ßALANINATE: A NOVEL SALT FOR INCREASING ATHLETIC PERFORMANCE | Aug 20, 2009 | Abandoned |
Array
(
[id] => 6547895
[patent_doc_number] => 20100016440
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-01-21
[patent_title] => 'ALPHA-AMINOAMIDE DERIVATIVES USEFUL AS ANTI-INFLAMMATORY AGENTS'
[patent_app_type] => utility
[patent_app_number] => 12/544456
[patent_app_country] => US
[patent_app_date] => 2009-08-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4299
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0016/20100016440.pdf
[firstpage_image] =>[orig_patent_app_number] => 12544456
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/544456 | ALPHA-AMINOAMIDE DERIVATIVES USEFUL AS ANTI-INFLAMMATORY AGENTS | Aug 19, 2009 | Abandoned |
Array
(
[id] => 6113769
[patent_doc_number] => 20110190356
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-08-04
[patent_title] => 'Compositions and Methods of Using (R)- Pramipexole'
[patent_app_type] => utility
[patent_app_number] => 13/059713
[patent_app_country] => US
[patent_app_date] => 2009-08-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 45360
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0190/20110190356.pdf
[firstpage_image] =>[orig_patent_app_number] => 13059713
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/059713 | Compositions and Methods of Using (R)- Pramipexole | Aug 18, 2009 | Abandoned |
Array
(
[id] => 7657371
[patent_doc_number] => 20110306640
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-12-15
[patent_title] => 'DABIGATRAN IN TUMOUR THERAPY'
[patent_app_type] => utility
[patent_app_number] => 13/058932
[patent_app_country] => US
[patent_app_date] => 2009-08-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3370
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0306/20110306640.pdf
[firstpage_image] =>[orig_patent_app_number] => 13058932
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/058932 | DABIGATRAN IN TUMOUR THERAPY | Aug 16, 2009 | Abandoned |
Array
(
[id] => 8063455
[patent_doc_number] => 20110245293
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-10-06
[patent_title] => 'PHARMACEUTICAL PRODUCT COMPRISING A MUSCARINIC RECEPTOR ANTAGONIST AND A BETA-2-ADRENOCEPTOR AGONIST'
[patent_app_type] => utility
[patent_app_number] => 13/058781
[patent_app_country] => US
[patent_app_date] => 2009-08-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 22830
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0245/20110245293.pdf
[firstpage_image] =>[orig_patent_app_number] => 13058781
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/058781 | PHARMACEUTICAL PRODUCT COMPRISING A MUSCARINIC RECEPTOR ANTAGONIST AND A BETA-2-ADRENOCEPTOR AGONIST | Aug 10, 2009 | Abandoned |
Array
(
[id] => 7574065
[patent_doc_number] => 20110269721
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-11-03
[patent_title] => 'METHODS OF TREATING THALASSEMIA'
[patent_app_type] => utility
[patent_app_number] => 13/057133
[patent_app_country] => US
[patent_app_date] => 2009-08-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 6741
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0269/20110269721.pdf
[firstpage_image] =>[orig_patent_app_number] => 13057133
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/057133 | METHODS OF TREATING THALASSEMIA | Aug 2, 2009 | Abandoned |
Array
(
[id] => 5993614
[patent_doc_number] => 20110015267
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-01-20
[patent_title] => 'METHODS FOR THE PREPARATION AND USE OF AQUEOUS SOLUTIONS OF MAGNESIUM VALPROATE HYDRATE AND L-CARNITINE'
[patent_app_type] => utility
[patent_app_number] => 12/505849
[patent_app_country] => US
[patent_app_date] => 2009-07-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6394
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0015/20110015267.pdf
[firstpage_image] =>[orig_patent_app_number] => 12505849
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/505849 | METHODS FOR THE PREPARATION AND USE OF AQUEOUS SOLUTIONS OF MAGNESIUM VALPROATE HYDRATE AND L-CARNITINE | Jul 19, 2009 | Abandoned |
Array
(
[id] => 7685330
[patent_doc_number] => 20100120811
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-05-13
[patent_title] => 'LONG-ACTING INJECTABLE ANALGESIC FORMULATIONS FOR ANIMALS'
[patent_app_type] => utility
[patent_app_number] => 12/505457
[patent_app_country] => US
[patent_app_date] => 2009-07-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 8175
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0120/20100120811.pdf
[firstpage_image] =>[orig_patent_app_number] => 12505457
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/505457 | LONG-ACTING INJECTABLE ANALGESIC FORMULATIONS FOR ANIMALS | Jul 16, 2009 | Abandoned |
Array
(
[id] => 9389400
[patent_doc_number] => 08685998
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-04-01
[patent_title] => 'Tacrolimus for improved treatment of transplant patients'
[patent_app_type] => utility
[patent_app_number] => 12/499034
[patent_app_country] => US
[patent_app_date] => 2009-07-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 38113
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 145
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12499034
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/499034 | Tacrolimus for improved treatment of transplant patients | Jul 6, 2009 | Issued |
Array
(
[id] => 7696035
[patent_doc_number] => 20110230555
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-09-22
[patent_title] => 'Enzyme Inhibitors and the Use Thereof'
[patent_app_type] => utility
[patent_app_number] => 12/999732
[patent_app_country] => US
[patent_app_date] => 2009-06-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13484
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0230/20110230555.pdf
[firstpage_image] =>[orig_patent_app_number] => 12999732
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/999732 | Enzyme Inhibitors and the Use Thereof | Jun 23, 2009 | Abandoned |
Array
(
[id] => 5458794
[patent_doc_number] => 20090258946
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-10-15
[patent_title] => 'ELECTROSTATICALLY CHARGED NASAL APPLICATION MULTIPURPOSE PRODUCTS AND METHOD'
[patent_app_type] => utility
[patent_app_number] => 12/489185
[patent_app_country] => US
[patent_app_date] => 2009-06-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1946
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0258/20090258946.pdf
[firstpage_image] =>[orig_patent_app_number] => 12489185
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/489185 | ELECTROSTATICALLY CHARGED NASAL APPLICATION MULTIPURPOSE PRODUCTS AND METHOD | Jun 21, 2009 | Abandoned |